Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Q307 PDS Income Statement

Q307 PDS Income Statement

posted on Apr 20, 2007 03:57PM

All,

Since this company makes every attempt to burry the numbers I have put together the following PDS Q307 income statement below just for transperancys sake. Since there was a receivable recorded in February for $2.9M for cash that will be received in March I am making the assumption that was Funai's license.

PDS Income Statement Q307
Licenses                    26,239,985
Expenses                      3,023,438
Interest                          96,655
Net PDS income                    23,313,202
50/50 split to PTSC                   11,656,601
PDS Breakdown                    26,239,985
Lexmark/Schneider                     7,320,000
NEC                   15,999,985
Funai                     2,920,000

Apr 20, 2007 05:35PM
Share
New Message
Please login to post a reply